Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Dec 6, 2015Virtual Press Office and PR Newswire: General Trade show news
Findings from an ongoing Phase IIa study to evaluate the safety and efficacy of investigational chimeric antigen receptor T cell (CART) therapy CTL019 in certain types of relapsed or refractory...
-
Dec 5, 2015Virtual Press Office and PR Newswire: General Trade show news
CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) and Baxalta Incorporated (Baxalta) (NYSE: BXLT) today announced results from a new analysis of the pivotal Phase 3 trial, PERSIST-1,...
-
Dec 5, 2015Virtual Press Office and PR Newswire: General Trade show news
Amgen (NASDAQ:AMGN) today announced the presentation of new key data evaluating Kyprolis® (carfilzomib) -based regimens in patients with relapsed multiple myeloma. The data showed Kyprolis in...
-
Dec 5, 2015Virtual Press Office and PR Newswire: General Trade show news
New research adds to a growing body of evidence that gene therapy, an experimental technique that involves correcting or replacing a person's mutated or malfunctioning genes, may improve health...
-
Dec 4, 2015Virtual Press Office and PR Newswire: General Trade show news
WHO: Andre Goy, M.D., M.S., Chairman, John Theurer Cancer Center and Chief, Division of Lymphoma, Hackensack University Medical Center; Andrew L. Pecora, MD, FACP, CPE, Vice President of Cancer...